EGFR and non-small cell lung carcinoma: Novel electrochemical sensor-based technologies like an electric field-induced release and measurement (EFIRM) developed by the Wong lab have been shown to detect EGFR mutations (tyrosine kinase domain) from bodily fluids like saliva in patients with non-small cell lung carcinoma (NSCLC) [179].